Abiopharma

🔍 Colgrove John (Director)

Company: Everpure, Inc. (PSTG)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Sold 58,552 shares of Class A Common Stock at $65.45 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,725,221.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 601,959.00 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 2,765,000.00 | Footnotes: F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 2,765,000.00 | Footnotes: F4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 100,000.00 | Footnotes: F5

Footnotes:

• F1: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of the Reporting Person's equity awards, previously reported on a Form 4, and does not represent a sale by the Reporting Person.
• F2: Shares are held by Colgrove Family Living Trust.
• F3: Shares are held by The EEC Irrevocable Trust. A member of the Reporting Person's immediate family is a beneficiary of the trust.
• F4: Shares are held by The RWC Irrevocable Trust. A member of the Reporting Person's immediate family is a beneficiary of the trust.
• F5: Shares are held by VCF Trust.